Cargando…

Sarilumab: Thrombocytopenia during an off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726276/ http://dx.doi.org/10.1007/s40278-020-87163-5

Ejemplares similares

Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020)

Multiple drugs: Thrombocytopenia and off-label use: 2 case reports
Publicado: (2021)

Sarilumab: Cytomegalovirus colitis: case report
Publicado: (2020)

Multiple drugs: Off label use and heparin-induced thrombocytopenia: case report
Publicado: (2020)

Favipiravir/levofloxacin/paracetamol: Severe thrombocytopenia and off-label use: case report
Publicado: (2021)

Sarilumab: Perforated duodenal ulcer: case report
Publicado: (2021)

Ceftriaxone/levofloxacin/lopinavir/ritonavir: Thrombocytopenia following off-label use: case report
Publicado: (2021)

Multiple drugs: Pneumatosis intestinalis, thrombocytopenia and off-label use: 4 case reports
Publicado: (2021)

Multiple drugs: Gastrointestinal disorders and thrombocytopenia following off-label use: 2 case reports
Publicado: (2020)

Severe thrombocytopenia in a patient with hepatitis C treated with eltrombopag from off-label drug use to on-label drug use: a case report
por: Al-Jafar, Hassan A, et al.
Publicado: (2014)

Subcutaneous Sarilumab in Patients With Rheumatoid Arthritis who Previously Received Subcutaneous Sarilumab or Intravenous Tocilizumab: An Open‐Label Extension of a Randomized Clinical Trial
por: Emery, Paul, et al.
Publicado: (2020)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Antineoplastics: Pancytopenia and off-label use: case report
Publicado: (2020)

Nafamostat: Off-label use and hyperkalaemia: case report
Publicado: (2020)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Hydroxychloroquine/oseltamivir: Exacerbation of psoriasis during off-label use: case report
Publicado: (2020)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Hydroxychloroquine: Lack of efficacy during off label use treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Dexamethasone: An atypical presentation of adrenal insufficiency during off-label use: case report
Publicado: (2021)

Tocilizumab: Candidaemia and Off-label-use: 3 case reports
Publicado: (2020)

Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)

Chloroquine: Off-label use, haemolysis and methaemoglobinaemia: case report
Publicado: (2020)

Multiple drugs: Lymphocytopenia and off-label use: case report
Publicado: (2020)

Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Publicado: (2020)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021)

Methylprednisolone: Bacteraemia following off label use: case report
Publicado: (2021)

Multiple drugs: No response and off label use: case report
Publicado: (2021)

Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Azithromycin: Lack of efficacy and off-label use: case report
Publicado: (2021)

Methylprednisolone: Worsening hyperglycaemia and off-label use: case report
Publicado: (2021)

Dexamethasone: Hyperglycaemia following off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Various toxicities and off-label use: case report
Publicado: (2022)

Methylprednisolone: Fungaemia following an off-label use: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n9tuikqdkitr229jh2d88pkqqt